Skip to main navigation Skip to search Skip to main content

BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer

  • Sungkyunkwan University

Research output: Contribution to journal › Article › peer-review

28   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science